Pfizer Sickle Cell Disease Medicine, Oxbryta, Withdrawn Due to Voxelotor Safety Concerns

Published:

  • Defective Products
Oxbryta Pfizer building

The rise and fall of Oxbryta in the sickle cell community.

Last Updated:

comments
share

Add Comment